Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02238951 · ClinicalTrials.gov registry record · NA

Cancer Care Coordination for Chemotherapy Patients

A NA study of Cancer, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT02238951 is a NA study of Cancer that has completed, run by University of California, Davis. The registered enrollment target is 60 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02238951, a NA study of Cancer, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare nurse-led care coordination for persons receiving cancer chemotherapy treatment incorporating mobile health technology to nurse-led care coordination without any mobile health enhancements.

Conditions Studied

Interventions

  • OTHER Mobile Health (mHealth)
  • OTHER No mHealth

Study Locations (1)

California

  • UC Davis Comprehensive Cancer Care Center - Sacramento

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2013-12
Est. Completion 2017-10
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT02238951

The ClinicalTrials.gov registry entry for NCT02238951 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Mobile Health (mHealth) is the first listed.

NCT02238951 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02238951 about?

NCT02238951 is a clinical study titled "Cancer Care Coordination for Chemotherapy Patients". The purpose of this study is to compare nurse-led care coordination for persons receiving cancer chemotherapy treatment incorporating mobile health technology to nurse-led care coordination without any mobile health enhancements.

What is the current status of trial NCT02238951?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2013-12. Estimated completion is 2017-10.

What conditions does trial NCT02238951 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT02238951?

The interventions under investigation include: Mobile Health (mHealth) (OTHER), No mHealth (OTHER).

Who is sponsoring clinical trial NCT02238951?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02238951 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.